Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-06-008394
Filing Date
2006-02-13
Accepted
2006-02-13 16:58:22
Documents
1
Group Members
CITADEL DERIVATIVES GROUP LLCCITADEL EQUITY FUND LTD.CITADEL INVESTMENT GROUP, L.L.C.CITADEL KENSINGTON GLOBAL STRATEGIES FUND LTD.CITADEL WELLINGTON LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT a06-4579_4sc13ga.htm SC 13G/A 246174
  Complete submission text file 0001104659-06-008394.txt   248454
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: SC 13G/A | Act: 34 | File No.: 005-37954 | Film No.: 06604490
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60603
Business Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60606 3123952100
CITADEL L P (Filed by) CIK: 0001027745 (see all company filings)

EIN.: 364111741 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G/A